Skip to content

Lactocare Baby Drops in Infants Colic

Role of Lactobacillus Rhamnosus (FloraActive™) 19070 and Lactobacillus Reuteri (FloraActive™) DSM 12246 in Infant Colic: a Controlled Dietary Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02839239
Acronym
LACONIC
Enrollment
168
Registered
2016-07-20
Start date
2016-12-09
Completion date
2018-01-15
Last updated
2018-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infant Colic

Brief summary

The objective of this study is to determine an efficacy of the combination of L. rhamnosus 19070-2 (FloraActiveTM) and L. reuteri DSM 122460 (FloraActiveTM) in decreasing cry/fuss in infants aged 4 through 12 weeks with IC. The active group of infants will receive lactobacilli with vitamin D3 while the control group will receive vitamin D3 2 times daily as oil suspension for 28 days. Duration of infant fuss/cry will be measured at baseline and at the end of intervention to define a difference between the groups

Detailed description

There is accumulating interest in role of lactobacilli in decreasing cry and fuss in infant colic, the condition that affects around 1 of 4-5 infants. The interest for dietary supplementation has been evoked by a line of earlier studies, indicating that infants with colic had an increased number of gas-forming E.coli in the intestines and potential interference between lactobacilli and E.coli. Systematic review of evidence, based on the 6 randomized controlled dietary studies, conducted in Italy, Poland, Australia, Canada, and Finland, has concluded of the decrease of the mean time cry of infant by -55 minutes a day after the 3 weeks dietary course with lactobacilli . In the mentioned studies most commonly used lactobacilli were L. reuteri, however, the effect of combination of L. reuteri with other lactobacilli remains unknown.

Interventions

DIETARY_SUPPLEMENTDrops with vitamin D3

Oil suspension with vitamin D3

DIETARY_SUPPLEMENTDrops with lactobacilli and vitamin D3

Oil suspension with lactobacilli and vitamin D3

Sponsors

Lviv National Medical University
CollaboratorOTHER
Biocare Copenhagen A/S
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
4 Weeks to 12 Weeks
Healthy volunteers
No

Inclusion criteria

1. Informed consent form signed by both parents. 2. Gender: males and females; 3. Age: 4 -12 weeks; 4. Infant colic, defined as cry/fussing lasting \> 3 h, occurring \> 3 d for 7 days; 5. Gestational age 37-42 weeks; 6. Birth weight 2,500-4,200 g; 7. Stated availability throughout the study period; 8. Sated availability of mobile phone or phone with answering machine.

Exclusion criteria

1. Any formula feeding in any amount; 2. Failure to thrive (weight gain less than 100 grams per week as averaged from the birth weight to the weight at entry); 3. Current maternal smoking; 4. Known moderate or severe disease of any systems (neural, skeletal, muscular, cutaneous, gastrointestinal, respiratory, genital, urinary, immune); 5. Present intake of antibiotics by infant or mother; 6. Present intake of prebiotics or probiotics by infant or mother; 7. Difficulty of parents to comprehend study requirements as judged by the physician; 8. Suspected parental alcohol or drug addiction as judged by the physician.

Design outcomes

Primary

MeasureTime frameDescription
Change in mean cry/fuss time (min/day) from day 0 through day 2828 daysChange in mean cry/fuss time

Secondary

MeasureTime frameDescription
Change in mean cry time (min/day) from day 0 through day 2828 daysChange in mean cry time
Change in mean fuss time (min/day) from day 0 through day 2828 daysChange in mean fuss time
Treatment success (percent) at 7, 14, 21, 28 days, defined as more than 25% and 50% reduction in cry time from baseline7, 14, 21, 28 daysOutcome Measure Description
Recovery success (percent) at 7, 14, 21, 28 days, defined as reduction in duration of cry time less than 3 hours per day (unmet Wessel criteria);7, 14, 21, 28 daysRecovery success
Cry and fuss time (min/day) on days 0, 7, 14, 21, 287, 14, 21, 28 daysCry and fuss time

Other

MeasureTime frameDescription
Infant sleep duration (min/day) on days 0, 7, 14, 21, 287, 14, 21, 28 daysInfant sleep duration
Change in maternal depression score from day 0 through day 2828 daysChange in maternal depression score

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026